Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases
Authors:
Open Access
- 15 May 2007
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (20) , 8269-8274
Abstract
Type I IFNs are unusually pleiotropic cytokines that bind to a single heterodimeric receptor and have potent antiviral, antiproliferative, and immune modulatory activities. The diverse effects of the type I IFNs are of differential therapeutic importance; in cancer therapy, an enhanced antiproliferative effect may be beneficial, whereas in the therapy of viral infections (such as hepatitis B and hepatitis C), the antiproliferative effects lead to dose limiting bone marrow suppression. Studies have shown that various members of the natural IFN-α family and engineered variants, such as IFN-con1, vary in the ratios between various IFN-mediated cellular activities. We used DNA shuffling to explore and confirm the hypothesis that one could simultaneously increase the antiviral and Th1-inducing activity and decrease the antiproliferative activity. We report IFN-α hybrids wherein the ratio of antiviral:antiproliferative and Th1-inducing: antiproliferative potencies are markedly increased with respsect to IFN-con1 (75- and 80-fold, respectively). A four-residue motif that overlaps with the IFNAR1 binding site and is derived by cross breeding with a pseudogene contributes significantly to this phenotype. These IFN-αs have an activity profile that may result in an improved therapeutic index and, consequently, better clinical efficacy for the treatment of chronic viral diseases such as hepatitis B virus, human papilloma virus, HIV, or chronic hepatitis C.Keywords
This publication has 19 references indexed in Scilit:
- A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-αExperimental Hematology, 2004
- IFN-α Subtypes Differentially Affect Human T Cell MotilityThe Journal of Immunology, 2004
- Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growthBritish Journal of Haematology, 2003
- Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-helper 1 responses in patients with chronic hepatitis CGastroenterology, 2002
- Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteinsCurrent Opinion in Biotechnology, 2001
- Human T cells elicit IFN-α secretion from dendritic cells following cell to cell interactionsEuropean Journal of Immunology, 2000
- Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis CGastroenterology, 2000
- The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I IFNsThe Journal of Immunology, 1998
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998
- The structure of eight distinct cloned human leukocyte interferon cDNAsNature, 1981